Weike Lai (维可莱)维可莱
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司
主要成分Active Ingredients
- 氨溴索Anxiu Suo
药物知识说明
氨溴索是一种在国家药监局注册认定的药品。该药品含有氨溴索-e92651e5等成分。
该药品关联的活性成分包括：氨溴索Anxiu Suo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司。
您可以探索含有相同成分的其他药品：氨溴索-e92651e5成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 维可莱) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氨溴索Anxiu Suo.
Manufacturers recorded for this product: 江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司.
Explore other medicines containing the same ingredient: 氨溴索 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 维可莱Recorded Chinese name: 维可莱
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 玻璃输液瓶装，每瓶100ml，含盐酸氨溴索0.03g与氯化钠0.9g。Recorded Chinese description: 玻璃输液瓶装，每瓶100ml，含盐酸氨溴索0.03g与氯化钠0.9g。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20031120
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20031120
Manufacturer
Chinese legal name: 江苏豪森药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20031120
生产企业
江苏豪森药业股份有限公司(国产)
适应症
适用于下述患者严重病例(中度)以上伴有痰液分泌不正常及排痰功能不良的急性、慢性呼吸道疾病，例如慢性支气管炎急性加重、喘息型支气管炎、支气管扩张及支气管哮喘的祛痰治疗。术后肺部并发症的预防性治疗。
用法用量
静脉滴注。成人及12岁以上儿童:每日2次，每次100ml(30mg，1瓶)。
不良反应
盐酸氨溴索氯化钠通常能很好耐受，曾有轻度的胃肠道副作用报道，主要为胃部灼热、消化不良和偶尔出现恶心、呕吐。过敏反应极少出现，主要为皮疹。极少病例报道出现严重的急性过敏性反应，但其与盐酸氨溴索的相关性尚不能肯定，这类病人通常对其他物质亦产生过敏。
禁忌
已知对盐酸氨溴索或其他配方成份过敏者不宜使用。
注意事项
1. 孕妇及哺乳期妇女慎用。2. 应避免同时服强力镇咳药。
贮藏
密闭遮光保存
规格
玻璃输液瓶装，每瓶100ml，含盐酸氨溴索0.03g与氯化钠0.9g。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.